Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended ...

Switzerland-based FKG Dentaire, a leader in dental equipment manufacturing, has expanded its market presence to the UK. This move is poised to bring advanced dental solutions to British dental ...

H. Lundbeck A/S (Lundbeck) announced that Vyepti® (eptinezumab) met the primary and all key secondary endpoints in SUNRISE, a phase III pivotal clinical trial predominantly conducted in Asia ...

Dental support organisation Benevis is revolutionising patient care by implementing an assisted hygiene delivery model. Designed to improve both efficiency and patient experience, this model aims to ...

Agfa HealthCare has announced a pivotal collaboration with St Jansdal Hospital to deploy cutting-edge imaging solutions. This significant move aims to enhance both the quality and efficiency of ...

David Finch, Assistant Director of Healthy Lives at the Health Foundation, commenting on National life tables – life expectancy in England and Wales: 2021 to 2023, said, “Today’s ONS release shows a ...

Shimadzu Corporation has invested in Rhinoflux Inc., a company pioneering carbon dioxide capture and biomass energy technologies, through its Shimadzu Future Innovation Fund (FIF). This investment ...

Responding to the Care Quality Commission’s State of Care report 2023/24, Director of Policy at the Health Foundation, Hugh Alderwick, said: “Following Lord Darzi’s stark diagnosis of the state of the ...

GSK is reinforcing its leadership in lupus treatment through a significant $300 million upfront agreement to acquire the clinical-stage T-cell engager technology. This deal underscores GSK’s ...

Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial in 1,200 adults with metabolic dysfunction-associated ...

The Agriculture and Horticulture Development Board has issued a vital alert to UK cattle farmers regarding a growing risk of lungworm infections. Due to prevailing weather conditions, the potential ...

In a strategic financial move, Acadia Pharmaceuticals has successfully sold a pediatric review voucher (PRV) for $150 million, resulting in a substantial $100 million profit. This transaction ...